CHEYENNE, Wyo., March 20, 2018 -- MJ Biotech, Inc. (FKA Michael James Enterprises, Inc.) (OTC:MJTV) announced that it executed a Joint Venture agreement with Marijuana Doctors.com located in Florida to provide CBD Teas manufactured by Zen’s Tea House. The CBD Teas will be sold at all the Marijuana Doctors Florida locations.
MarijuanaDoctors.com was founded as the trusted gateway for patients searching for medical marijuana treatment in legal medical marijuana states. We provide patients visibility and transparency in selecting a doctor and setting an appointment for a medical marijuana evaluation including detailed profile information, scheduling information, and ratings and reviews. We understand the uncertainty associated with the process and that medical marijuana is often the only effective treatment for many ailments for which traditional medicine provides little relief or is accompanied by uncomfortable and dangerous side effects.
Conference Call update.
The Conference call update will be delayed due to the most recent Joint Venture agreement. The new date will be announced this week.
Due to the new Joint Venture agreement if there are additional questions regarding this Press Release please send them to [email protected].
Also Fernando Lopez the COO of MJ Biotech and President of Zen Tea House just did a new face book live with a Certified Holistic Nutritionist (FNS, CNPM, CHNP) about the benefits of teas & nutrition. This video can be seen at Facebook at https://www.facebook.com/zensteahouse.
Additional information is available on the company’s websites, www.mjbiotech.us and www.zenstea.com
Safe Harbor Statement
This release contains forward-looking statements, which are made pursuant to the safe harbor provisions of the U.S. Private Securities Litigation Reform Act of 1995. Forward-looking statements are commonly identified by words such as "would," "may," "will," "expects," and other terms with similar meaning. Forward-looking statements are based on current beliefs, assumptions and expectations and speak only as of the date of this release and involve risks and uncertainties that could cause actual results to differ materially from current expectations. We assume no obligation to update or revise any forward-looking statement, whether because of new information, future events or any other reason.
The above news release has been provided by the above company via the OTC Disclosure and News Service. Issuers of news releases and not OTC Markets Group Inc. are solely responsible for the accuracy of such news releases.
Contact
Fernando Lopez
[email protected]


Samsung, SK Hynix Test AMEC Chipmaking Tools for China Backup Plan
Glencore Posts Strong H1 2026 Earnings, Announces ASX Secondary Listing
Heineken H1 Operating Profit Meets Forecast as Beer Volumes Beat Expectations
SoftBank Q1 Profit Beats Forecast as Intel Rally and OpenAI Investments Boost Returns
UK AI Security Tests Reveal Anthropic and OpenAI Agents Attempted Unauthorized Actions
Jetstar to Charge for Overhead Cabin Bags From February
DoorDash Q2 Revenue Jumps 36% as Orders and DashPass Growth Drive Results
HSBC H1 Profit Jumps 23%, Announces $1 Billion Share Buyback and Reaffirms 2028 Targets
DHL Q2 Profit Jumps 24% as Express Business Drives Growth
Sinopec Boosts Russian ESPO Oil Purchases as Middle East Supply Tightens
Infineon Raises 2026 Revenue Outlook as AI Data Center Demand Fuels Record Quarterly Sales
Qantas Shares Climb as Long-Haul Pilot Deal Eases Strike Concerns
Shein Targets $30B-$40B Valuation in Hong Kong IPO Planned for August
Western Digital Q4 Earnings Beat Estimates as FY2027 Outlook Tops Expectations
Moderna Wins FDA Approval for mFLUSIVA mRNA Flu Vaccine for Adults 50+
BHP Port Hedland Strike Set to Proceed as Wage Talks Continue
SanDisk Q4 Earnings Beat Estimates as Q1 Revenue Outlook Meets Expectations 



